Learning Objectives

I. Pulmonary Hypertension and the Right Heart
08:10 Is the Pulmonary Hypertension Pre- or Post-Capillary? Acute or Chronic? What Is Its Etiology?
Dr. Jonathan Afilalo, Jewish General Hospital, McGill University, Montreal, QC
1. Appreciate the value of echocardiography in the characterization of pulmonary hypertension
2. Recognize echocardiographic features in the diagnosis of pulmonary hypertension that relate to pathophysiology, chronicity, and etiology
3. Describe echocardiographic prognostic features that relate to clinical outcome
08:35 The RV Is the Trickiest Chamber to Quantify! How Can 3D and Strain Help?
Dr. Sarah Blissett, London Health Sciences Centre, Western University, London, ON
1. Appreciate the complexity of RV shape and its challenges in quantifying size and function
2. Understand the incremental value of 3D echocardiography to accurately and reproducibly quantify RV size and function
3. Appreciate the incremental value of strain imaging to quantify clinical and subclinical RV systolic function
   

II. La cardiomyopathie hypertrophique
09:15 Reconnaître et démontrer une cardiomyopathie hypertrophique : rôle clé du technologue
Jessica Marcoux, Centre hospitalier universitaire de Sherbrooke, Université Sherbrooke, Sherbrooke, QC
1. Know the echocardiographic clues that suggest the presence of hypertrophic cardiomyopathy
2. Review tips to differentiate the Doppler signals of left ventricular outflow tract obstruction, intra-cavitary gradient, mitral regurgitation
3. Describe optimal techniques to perform dynamic interrogation of a left ventricular outflow tract obstruction
09:35 Imagerie multimodale pour le diagnostic et le suivi de la cardiomyopathie hypertrophique en 2023
Dr. Christine Henri, Institut de cardiologie de Montréal, Université de Montréal, Montréal, QC
1. Recognize the strengths and limitations of various imaging modalities for the diagnosis and management of hypertrophic cardiomyopathy
2. Demonstrate the role of stress echocardiography in the care of patients with hypertrophic cardiomyopathy
3. Discuss the impact of emerging treatments on the approach to imaging for these patients
   

III. La Valve mitrale rhumatismale et non-rhumatismale
10:35 Évaluation de la sténose mitrale rhumatismale : astuces en ETT et en ETO 3D
Dr. Jonathan Beaudoin, Institut universitaire de pneumologie et de cardiologie de Québec, Université Laval, Québec, QC
1. Understand the principles underlying the anatomic and hemodynamic quantifications of rheumatic mitral stenosis using traditional 2D/Doppler echocardiography and new 3D-derived approaches
11:00 Maladie mitrale dégénérative et calcifications annulaires : pourquoi et comment les décrire dans votre rapport ?
Dr. David Messika-Zeitoun, Institut de cardiologie de l'Université d'Ottawa, Ottawa, ON
1. Appreciate the increased prevalence of calcific mitral stenosis and understand the specific challenges of quantifying this disease entity
2. Apply evidence-based quantification methods in calcifying mitral stenosis
   

IV. L’intelligence artificielle
11:40 Comment l'intelligence artificielle va-t-elle améliorer nos performances en tant qu'échographistes et technologues ?
Dr. François Tournoux, Centre hospitalier de l'Université de Montréal, Université de Montréal, Montréal, QC
1. Understand how artificial intelligence (AI) can facilitate the acquisition of the echocardiographic examination
2. Appreciate the potential applications of AI for echocardiographic diagnosis and assessment
3. Recognize the growing importance of AI in the management of patient trajectories
   

V. The Tricuspid Valve
13:15 Keynote Presentation / Conférencier d’honneur
Integrative Imaging and Quantification in Tricuspid Regurgitation
Dr. Rebecca Hahn, Columbia University Irving Medical Center, New York, NY
1. Appreciate acquisition and interpretation beads for quantification of tricuspid regurgitation
2. Learn the importance and gain the skills to integrate various methods for the accurate quantification of this valvular disease
14:00 Extraordinary Cases of Tricuspid Regurgitation – Images You Won’t Want to Miss!
Dr. Valéry Legris, McGill University, Sylvain Lemay, Université de Montréal, Dr. Mary Philip, McGill University; Montreal, QC
1. Using a case-based approach, demonstrate key principles in the evaluation of tricuspid regurgitation by imaging.
15:00 Is the Cardiac Implantable Electronic Device Causing My Patient’s TR? Echo to the Rescue!
Dr. Karima Addetia, University of Chicago Heart and Vascular Center, University of Chicago, Chicago, IL
1. Indicate the different mechanisms by which cardiac implantable electronic devices may interfere with the tricuspid apparatus.
2. Demonstrate how to diagnose CIED-mediated interference on echocardiography
3. Review the clinical impact of CIED-mediated tricuspid regurgitation and the approach to management.
15:30 Trans-Catheter Approaches to TR: Role of Echo in Deciding Who, When and How
Dr. Jean Buithieu, McGill University Health Centre, McGill University, Montreal, QC
1. Compare the current and emerging trans-catheter treatments for tricuspid regurgitation
2. Demonstrate how echocardiography guides patient selection for trans-catheter treatment of tricuspid regurgitation
3. Discuss considerations in performing intra-procedural echocardiography for these treatments

Copyright 2023 - IS Event Solutions
514-991-3851   |    514-227-5083   |    This email address is being protected from spambots. You need JavaScript enabled to view it.